Share
))
My Body Odyssey chronicles the rewards and challenges of individuals pursuing active lifestyles despite chronic illness, recurrent injury, behavioral issues and more. Their stories are complemented by insights from researchers, medical doctors, physical therapists, psychologists, and other wellness experts. An award-winning show, My Body Odyssey will be launching Season Two later this year. Subscribe and stay tuned to learn more! www.mybodyodyssey.com
…
continue reading
E161 - Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World Setting Among Patients with Treatment Refractory Depression
Manage episode 343140376 series 1778252
Content provided by Neuroscience Education Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Neuroscience Education Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://cloudutil.player.fm/legal.
What are some of the major differences between intravenous or IV ketamine and intranasal esketamine? How are you building on these research findings and what associated avenues have been explored?
In this episode, we interview the poster winner from last year’s NEI Congress, Dr. Balwinder Singh on his research comparing intravenous ketamine and intranasal esketamine. The study, conducted at Mayo Clinic rendered interesting findings that may be important for clinicians.
Dr. Balwinder Singh is a Consultant and Assistant professor in the Department of Psychiatry at Mayo Clinic in Rochester, Minnesota. He is a psychiatrist specializing in mood disorders, and his research is focused on novel treatments for treatment-resistant depression and identifying biomarkers for ketamine response. He is also involved in the ketamine and esketamine clinic practice at the Mayo Clinic Depression Center.
This is one of the first studies to highlight a faster response to intravenous ketamine as compared to intranasal esketamine in an observational study.
Title: Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study Byline: Balwinder Singh; Simon Kung; Vanessa Pazdernik; Kathryn M. Schak; Jennifer Geske; Phillip J. Schulte; Mark A. Frye; Jennifer L. Vande Voort Citation: J Clin Psychiatry 2023;84(2):22m14548 DOI: https://doi.org/10.4088/JCP.22m14548 URL: Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study | Psychiatrist.com
195 episodes
